載入...
In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
BACKGROUND: NXL104 is a novel-structure β-lactamase inhibitor with potent activity against both class A and class C enzymes. Among the class A carbapenemases, KPC-type enzymes are now spreading rapidly and KPC-related carbapenemase resistance is an emerging phenomenon of great clinical importance. T...
Na minha lista:
Main Authors: | , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2009
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2707266/ https://ncbi.nlm.nih.gov/pubmed/19493866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkp197 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|